- Home
- KIDS vs CRMD Comparison
KIDS vs CRMD Comparison
Compare KIDS & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KIDS | CRMD |
|---|---|---|
| Founded | 2007 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 524.3M | 943.9M |
| IPO Year | 2017 | 2010 |
Fundamental Metrics
Financial Performance| Metric | KIDS | CRMD |
|---|---|---|
| Price | $17.34 | $12.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $24.75 | $17.43 |
| AVG Volume (30 Days) | 176.7K | ★ 2.6M |
| Earning Date | 10-28-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.25 |
| Revenue | ★ $227,410,000.00 | $214,303,672.00 |
| Revenue This Year | $16.58 | $627.89 |
| Revenue Next Year | $12.46 | $40.95 |
| P/E Ratio | ★ N/A | $5.41 |
| Revenue Growth | 19.90 | ★ 1647.67 |
| 52 Week Low | $15.28 | $5.60 |
| 52 Week High | $27.60 | $17.43 |
Technical Indicators
Market Signals| Indicator | KIDS | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 46.86 | 63.43 |
| Support Level | $16.88 | $11.78 |
| Resistance Level | $18.36 | $12.51 |
| Average True Range (ATR) | 0.72 | 0.51 |
| MACD | -0.12 | 0.13 |
| Stochastic Oscillator | 20.00 | 85.18 |
Price Performance
Historical ComparisonAbout KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.